Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jad Chahoud

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Cancers|July 29, 2023
The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma-A Systematic ReviewKevin Parza, Arfa Mustasam, Filip Ionescu, et al.
JAMA Oncology|August 10, 2023
Immunotherapy in the Treatment of Localized Genitourinary CancersAndrea Necchi, Bishoy M Faltas, Susan F Slovin, et al.
JAMA Oncology|December 13, 2019
Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Randomized Clinical TrialsSafae Terrisse, Eleni Karamouza, Chris C Parker, et al.
Cancers|November 13, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Potential Marker of HPV-Independent DiseaseJamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
The Journal of Urology|May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder CancerNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Marker of HPV-Independent DiseaseJamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
JAMA Network Open|May 25, 2021
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Cancers|March 13, 2024
Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell CarcinomaNiki M Zacharias, Luis Segarra, Keiko Akagi, et al.
Scientific Reports|March 5, 2025
Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinomaHiroko Miyagi, Xiaoqing Yu, Taylor Peak, et al.
European Urology Oncology|February 16, 2023
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell CarcinomaNeil T Mason, Vidhu B Joshi, Jacob J Adashek, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Cancers|July 29, 2023
The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma-A Systematic ReviewKevin Parza, Arfa Mustasam, Filip Ionescu, et al.
JAMA Oncology|August 10, 2023
Immunotherapy in the Treatment of Localized Genitourinary CancersAndrea Necchi, Bishoy M Faltas, Susan F Slovin, et al.
JAMA Oncology|December 13, 2019
Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Randomized Clinical TrialsSafae Terrisse, Eleni Karamouza, Chris C Parker, et al.
Cancers|November 13, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Potential Marker of HPV-Independent DiseaseJamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
The Journal of Urology|May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder CancerNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Tissue Factor Expression in Penile Squamous Cell Carcinoma: A Marker of HPV-Independent DiseaseJamaal C Jackson, Andrew C Johns, Leticia Campos Clemente, et al.
JAMA Network Open|May 25, 2021
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Cancers|March 13, 2024
Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell CarcinomaNiki M Zacharias, Luis Segarra, Keiko Akagi, et al.
Scientific Reports|March 5, 2025
Progressive T cell exhaustion and predominance of aging tissue associated macrophages with advancing disease stage in penile squamous cell carcinomaHiroko Miyagi, Xiaoqing Yu, Taylor Peak, et al.
European Urology Oncology|February 16, 2023
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell CarcinomaNeil T Mason, Vidhu B Joshi, Jacob J Adashek, et al.
Pageof 10